US equities |
META $620.19 ▼-1.64% MU $928.76 ▲+2.77% NVDA $217.94 ▲+0.90% TSLA $407.46 ▲+4.04% SPCX $148.58 ▲+1.14% AAPL $347.10 ▲+0.93% AMD $560.26 ▲+5.45% MSFT $531.33 ▼-0.24%
FinancialContent

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.81 +0.76 (+6.88%)
Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
33 34 Next >
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 26, 2023 ↗
 
Via Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
Psychedelic Stock Gainers And Losers From January 17, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023 ↗
 
Via Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023 ↗
 
Via Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook ↗
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 23, 2023 ↗
 
Via Benzinga
News headline image
Largest Psychedelic Stocks +3% This Week; Now +15% YTD ↗
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different... 
Via Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023 ↗
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023 ↗
 
Via Benzinga
News headline image
Psychedelics Market Could Reach $12B By 2029, Says New Report ↗
A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before... 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On? ↗
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday. 
Via Benzinga
News headline image
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances ↗
Once considered the realm of ancient civilizations and countercultures, psychedelics have in the past few years been seeing increasing interest.  
Via Benzinga
News headline image
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More ↗
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
Via Benzinga
News headline image
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023 ↗
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major... 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023 ↗
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results ↗
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 9, 2023 ↗
 
Via Benzinga
News headline image
My "Rags-To-Riches" Portfolio For 2023: An Introduction ↗
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up? 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From January 3, 2023 ↗
 
Via Benzinga
News headline image
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways ↗
What a year for psychedelics! 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
33 34 Next >